UPC-logo.png
Universe Pharmaceuticals INC Announces Closing of Initial Public Offering
March 25, 2021 16:20 ET | Universe Pharmaceuticals INC
Ji’an, Jiangxi, China, March 25, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the closing...
barup-logo.png
MICT Announces $54 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
March 03, 2021 08:30 ET | MICT, Inc.
MONTVALE, N.J., March 03, 2021 (GLOBE NEWSWIRE) -- MICT, Inc. (Nasdaq: MICT) (the "Company"), today announced it has entered into securities purchase agreements with institutional investors for the...
Logo 1.jpg
Verano Holdings Announces C$100 Million Bought Deal Private Placement of Special Warrants
February 24, 2021 08:20 ET | Verano Holdings Corp.
Chicago, IL, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (“Verano” or the “Company”) (CSE: VRNO) is pleased to announce that it has entered into an agreement with Beacon Securities...
Logo.png
Ebang International Announces Completion of Follow-on Public Offering and Exercise of Warrants for Approximately $72.4 Million in Gross Proceeds
February 22, 2021 09:15 ET | EBANG INTERNATIONAL HOLDINGS INC.
HANGZHOU, China, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (Nasdaq: EBON, the “Company,” “we” or “our”), a blockchain technology company in the global market, today announced...
Logo 1.png
Aeterna Zentaris Announces Closing of $29.7 Million Bought Deal Offering of Common Shares
February 19, 2021 13:25 ET | Aeterna Zentaris Inc
CHARLESTON, S.C., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and...
Imagin Medical LOGO.jpg
IMAGIN MEDICAL CLOSES SECOND TRANCHE OF CONVERTIBLE NOTE OFFERING
February 18, 2021 08:30 ET | Imagin Medical Inc.
Vancouver, B.C. and Boston, MA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD3) (“Imagin” or the...
univest-logo.png
Univest Securities, LLC. Announces Closing of $70 Million Follow-on Offering for its Client Ebang International Holdings Inc. (Nasdaq: EBON)
February 17, 2021 16:00 ET | Univest Securities, LLC
New York, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Univest Securities, LLC, a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today...
Form fit function.png
Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock
February 12, 2021 08:30 ET | Conformis, Inc.
BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its common stock at an...
Form fit function.png
Conformis, Inc. Announces Proposed Public Offering of Common Stock
February 11, 2021 16:01 ET | Conformis, Inc.
BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced that it intends to offer shares of its common stock in an underwritten public offering. Conformis...
revive-therapeutics.png
Revive Therapeutics Receives Receipt for Final Short-Form Prospectus for Previously Announced $20 Million Bought Deal Public Offering
February 09, 2021 17:00 ET | Revive Therapeutics Ltd.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:RVV) (USA:...